SCHEDULE: Cormorant Asset Management Increases Stake in iBio

Cormorant Asset Management, LP and Bihua Chen have reported an increased beneficial ownership of iBio, Inc. common stock, reaching 9.99% through the exercise of warrants.

Summary

• Cormorant Asset Management, LP and Bihua Chen, collectively referred to as the Reporting Persons, have filed an amendment to their Schedule 13G, indicating an increase in their beneficial ownership of iBio, Inc. common stock.
• The Reporting Persons now beneficially own 3,834,335 shares of iBio's common stock, representing 9.99% of the class.
• This ownership is primarily derived from shares issuable upon the exercise of pre-funded warrants and/or Series G warrants. The exercise of these warrants is subject to a 9.99% beneficial ownership limitation.
• If not for this limitation, the Reporting Persons would beneficially own more than 9.99% of iBio's common stock.
• The filing also notes that 3,570,000 shares issuable upon exercise of a Series H warrant are not included in the current holdings, as this warrant is only exercisable upon the exercise of the Series G warrant.
• The percentage of class calculation is based on iBio's Quarterly Report on Form 10-Q for the period ended December 31, 2025, which stated 34,543,561 shares outstanding as of February 9, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports on increased beneficial ownership through warrant exercises rather than new strategic initiatives or financial performance updates from the company itself.

Positives

• Cormorant Asset Management and Bihua Chen have increased their stake in iBio, Inc., signaling confidence or strategic interest in the company.
• The Reporting Persons hold shared voting and dispositive power over 3,834,335 shares, indicating significant influence.
• The ownership level of 9.99% is a notable threshold, often indicating a substantial passive investment.

Negatives

• The beneficial ownership is capped at 9.99% due to warrant exercise limitations, preventing a larger stake without further action or waiver.
• A significant number of shares (3,570,000) issuable from a Series H warrant are not currently included in the reported beneficial ownership.

Risks

• The exercise of warrants is subject to a 9.99% ownership cap, which could limit future increases in beneficial ownership.
• The reliance on warrant exercises means the ownership is contingent on the terms and conditions of those warrants.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from iBio, Inc. It primarily details the current ownership structure and holdings of the Reporting Persons.

Industry Context

StockSavvy.ai notes that significant stake-building by investment firms, particularly reaching the 9.99% threshold, often signals a heightened level of investor interest or potential activism in the biotechnology sector, where companies like iBio operate.

Stakeholder Impact

• Shareholders: The increased stake by Cormorant Asset Management and Bihua Chen may signal increased investor interest, potentially influencing market perception and share price.
• Management and Board of Directors: A 9.99% ownership stake can bring increased scrutiny and potential influence on corporate strategy and governance decisions.

Next Steps

• The Reporting Persons may continue to exercise warrants up to the 9.99% ownership limit.
• Further filings may be required if the Reporting Persons' ownership changes significantly or if they decide to exercise the Series H warrant.

Key Dates

Recommendation

This filing indicates an increase in beneficial ownership by a significant investor through warrant exercises, reaching a 9.99% stake. While this suggests investor interest, it does not provide new operational or financial information about iBio, Inc. itself. Therefore, a 'hold' recommendation is appropriate pending further company-specific developments or strategic disclosures.

Keywords

iBio Inc, Schedule 13G, Cormorant Asset Management, Bihua Chen, Beneficial Ownership, Warrants, Common Stock, SEC Filing, Investment